Colonization status and appropriate antibiotic therapy for nosocomial bacteremia caused by antibiotic-resistant gram-negative bacteria in an intensive care unit

Infect Control Hosp Epidemiol. 2005 Jun;26(6):575-9. doi: 10.1086/502575.

Abstract

Objective: Timely initiation of antibiotic therapy is crucial for severe infection. Appropriate antibiotic therapy is often delayed for nosocomial infections caused by antibiotic-resistant bacteria. The relationship between knowledge of colonization caused by antibiotic-resistant gram-negative bacteria (ABR-GNB) and rate of appropriate initial antibiotic therapy for subsequent bacteremia was evaluated.

Design: Retrospective cohort study.

Setting: Fifty-four-bed intensive care unit (ICU) of a university hospital. In this unit, colonization surveillance is performed through routine site-specific surveillance cultures (urine, mouth, trachea, and anus). Additional cultures are performed when presumed clinically relevant.

Patients: ICU patients with nosocomial bacteremia caused by ABR-GNB.

Results: Infectious and microbiological characteristics and rates of appropriate antibiotic therapy were compared between patients with and without colonization prior to bacteremia. Prior colonization was defined as the presence (detected > or = 2 days before the onset of bacteremia) of the same ABR-GNB in colonization and subsequent blood cultures. During the study period, 157 episodes of bacteremia caused by ABR-GNB were suitable for evaluation. One hundred seventeen episodes of bacteremia (74.5%) were preceded by colonization. Appropriate empiric antibiotic therapy (started within 24 hours) was administered for 74.4% of these episodes versus 55.0% of the episodes that occurred without prior colonization. Appropriate therapy was administered within 48 hours for all episodes preceded by colonization versus 90.0% of episodes without prior colonization.

Conclusion: Knowledge of colonization status prior to infection is associated with higher rates of appropriate therapy for patients with bacteremia caused by ABR-GNB.

MeSH terms

  • Anal Canal / microbiology
  • Anti-Bacterial Agents / therapeutic use*
  • Bacteremia* / diagnosis
  • Bacteremia* / drug therapy
  • Bacteremia* / epidemiology
  • Bacteremia* / microbiology
  • Belgium / epidemiology
  • Clinical Protocols / standards
  • Cost-Benefit Analysis
  • Critical Care / economics
  • Critical Care / methods
  • Critical Care / standards
  • Cross Infection* / diagnosis
  • Cross Infection* / drug therapy
  • Cross Infection* / epidemiology
  • Cross Infection* / microbiology
  • Drug Resistance, Bacterial
  • Gram-Negative Bacterial Infections* / diagnosis
  • Gram-Negative Bacterial Infections* / drug therapy
  • Gram-Negative Bacterial Infections* / epidemiology
  • Gram-Negative Bacterial Infections* / microbiology
  • Hospitals, University
  • Humans
  • Incidence
  • Infection Control / economics
  • Infection Control / methods
  • Infection Control / standards
  • Length of Stay / statistics & numerical data
  • Microbial Sensitivity Tests
  • Mouth / microbiology
  • Patient Selection*
  • Predictive Value of Tests
  • Retrospective Studies
  • Specimen Handling / economics
  • Specimen Handling / methods
  • Specimen Handling / standards
  • Time Factors
  • Trachea / microbiology
  • Urine / microbiology

Substances

  • Anti-Bacterial Agents